The β-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 7, 2006, Pages 3178-3186

  Osborne, Neville N ^a   Wood, John P M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARTEOLOL; DEACETYLMETIPRANOLOL; LATANOPROST; METIPRANOLOL; TRAVOPROST; TROLOX C; ZINC;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; NICK END LABELING; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA CELL; WESTERN BLOTTING; ANIMAL; CATTLE; CELL PROTECTION; CELL SURVIVAL; DRUG EFFECT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IN SITU NICK-END LABELING; LIPID PEROXIDATION; METIPRANOLOL; OXIDATIVE STRESS; PHOTORECEPTORS, VERTEBRATE; PIGMENT EPITHELIUM OF EYE; RATS; RATS, WISTAR; ZINC;

EID: 33746695565     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1370     Document Type: Article

References (64)

1. Beyersmann D, Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals. 2001;14:331-341.
2. Kimura E, Kikuta E. Why zinc in zinc enzymes? - from biological roles to DNA base-selective recognition. J Biol Inorg Chem. 2000;5:139-155.
3. Frederickson CJ, Moncrieff DW. Zinc-containing neurons. Biol Signals. 1994;3:127-139.
4. Tonder N, Johansen FF, Frederickson CJ, Zimmer J, Diemer NH. Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci Lett. 1990;109:247-252.
5. Long Y, Frederickson CJ. A zinc-containing fiber system of thalamic origin. Neuroreport. 1994;5:2026-2028.
6. Ugarte M, Osborne NN. Zinc in the retina. Prog Neurobiol. 2001;64:219-249.
7. Ugarte M, Osborne NN. The localization of endogenous zinc and the in vitro effect of exogenous zinc on the GABA immunoreactivity and formation of reactive oxygen species in the retina. Gen Pharmacol. 1998;30:297-303.
8. Grahn BH, Paterson PG, Gottschall Pass KT, Zhang Z. Zinc and the eye. J Am Coll Nutr. 2001;20:106-118.
9. Akagi T, Kaneda M, Ishii K, Hashikawa T. Differential subcellular localization of zinc in the rat retina. J Histochem Cytochem. 2001;49:87-96.
10. Wu SM, Qiao X, Noebels JL, Yang XL. Localization and modulatory actions of zinc in vertebrate retina. Vision Res. 1993;33:2611-2616.
11. Zhao YJ, Yang GY, Domino EF. Zinc protoporphyrin, zinc ion, and protoporphyrin reduce focal cerebral ischemia. Stroke. 1996;27:2299-2303.
12. Choi DW, Koh JY. Zinc and brain injury. Ann Rev Neurosci. 1998;21:347-375.
13. Ahn YH, Kim YH, Hong SH, Koh JY. Depletion of intracellular zinc induces protein synthesis-dependent neuronal apoptosis in mouse cortical culture. Exp Neurol. 1998;154:47-56.
14. Choi DW, Yokoyama M, Koh J. Zinc neurotoxicity in cortical cell culture. Neuroscience. 1988;24:67-79.
15. 2+ entry produces oxidative neuronal necrosis in cortical cell cultures. Eur J Neurosci. 1999;11:327-334.
16. Lobner D, Canzoniero LM, Manzerra P, et al. Zinc-induced neuronal death in cortical neurons. Cell Mol Biol. 2000;46:797-806.
17. Manev H, Kharlamov E, Uz T, Mason RP, Cagnoli CM. Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Exp Neurol. 1997;146:171-178.
18. 2+ from brain tissue during activity. Nature. 1984;308:734-736.
19. Cuajungco MP, Lees GJ. Prevention of zinc neurotoxicity in vivo by N,N,N′,N′-tetrakis (2-pyridylmethyl) ethylene-diamine (TPEN). Neuroreport. 1996;7:1301-1304.
20. Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 1996;272:1013-1016.
21. Matsushita K, Kitagawa K, Matsuyama T, et al. Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus. Brain Res. 1996;743:362-365.
22. Suh SW, Chen JW, Motamedi M, et al. Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res. 2000;852:268-273.
23. Lin AM, Fan SF, Yang DM, Hsu LL, Yang CH. Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radic Biol Med. 2003;34:1416-1425.
24. Kim YH, Kim EY, Gwag BJ, Sohn S, Koh JY. Zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals. Neuroscience. 1999;89:175-182.
25. Wood JP, Osborne NN. The influence of zinc on caspase-3 and DNA breakdown in cultured human retinal pigment epithelial cells. Arch Ophthalmol. 2001;119:81-88.
26. Wood JP, Osborne NN. Zinc and energy requirements in induction of oxidative stress to retinal pigmented epithelial cells. Neurochem Res. 2003;28:1525-1533.
27. Sheline CT, Behrens MM, Choi DW. Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis. J Neurosci. 2000;20:3139-3146.
28. Park JA, Koh JY. Induction of an immediate early gene egr-1 by zinc through extracellular signal-regulated kinase activation in cortical culture: its role in zinc-induced neuronal death. J Neurochem. 1999;73:450-456.
29. Noh KM, Kim YH, Koh JY. Mediation by membrane protein kinase C of zinc-induced oxidative neuronal injury in mouse cortical cultures. J Neurochem. 1999;72:1609-1616.
30. Jiang D, Sullivan PG, Sensi SL, Steward O, Weiss JH. Zn(2+) induces permeability transition pore opening and release of proapoptotic peptides from neuronal mitochondria. J Biol Chem. 2001;276:47524-47529.
31. Zarbin MA. Age-related macular degeneration: review of pathogenesis. Eur J Ophthalmol. 1998;8:199-206.
32. Adler R, Curcio C, Hicks D, Price D, Wong F. Cell death in age-related macular degeneration. Mol Vis. 1999;5:31.
33. King A, Gottlieb E, Brooks DG, Murphy MP, Dunaief JL. Mitochondria-derived reactive oxygen species mediate blue light-induced death of retinal pigment epithelial cells. Photochem Photobiol. 2004;79:470-475.
34. Melena J, Osborne NN. Metipranolol attenuates lipid peroxidation in rat brain: a comparative study with other antiglaucoma drugs. Graefes Arch Clin Exp Ophthalmol. 2003;241:827-833.
35. Osborne NN, Wood JP. Metipranolol blunts nitric oxide-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs. Invest Ophthalmol Vis Sci. 2004;45:3787-3795.
36. Tomita I, Sano M, Serizawa S, Ohta K, Katou M. Fluctuation of lipid peroxides and related enzyme activities at time of stroke in stroke-prone spontaneously hypertensive rats. Stroke. 1979;10:323-326.
37. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
38. Osborne N, Cazevieille C, Pergande G, Wood J. Induction of apoptosis in cultured human retinal pigmented epithelial cells is counteracted by flupirtine. Invest Ophthalmol Vis Sci. 1997;38:1390-1400.
39. Wood J, Osborne N. Induction of apoptosis in cultured human retinal pigmented epithelial cells: the effect of protein kinase C activation and inhibition. Neurochemistry Int. 1997;31:261-274.
40. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
41. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354.
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
43. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106:192-198.
44. Mares Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.
45. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1225-1235.
46. AREDS. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: Report No. 8. Arch Ophthalmol. 2001;119:1417-1436.
47. Jampol LM. Antioxidants and zinc to prevent progression of age-related macular degeneration. JAMA. 2001;286:2466-2468.
48. AREDS. The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. J Nutr. 2002;132:697-702.
49. Comer GM, Ciulla TA, Criswell MH, Tolentino M. Current and future treatment options for nonexudative and exudative age-related macular degeneration. Drugs Aging. 2004;21:967-992.
50. Tate DJ Jr, Miceli MV, Newsome DA. Zinc protects against oxidative damage in cultured human retinal pigment epithelial cells. Free Radic Biol Med. 1999;26:704-713.
51. Miceli MV, Tate DJ Jr, Alcock NW, Newsome DA. Zinc deficiency and oxidative stress in the retina of pigmented rats. Invest Ophthalmol Vis Sci. 1999;40:1238-1244.
52. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-1420.
53. Vanden-Langenberg GM, Mares Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148:204-214.
54. Raha S, Robinson BH. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet. 2001;106:62-70.
55. Zhao X, Huang J, Khani SC, Palczewski K. Molecular forms of human rhodopsin kinase (GRK1). J Biol Chem. 1998;273:5124-5131.
56. Shvedova AA, Alekseeva OM, Kuliev I, et al. Damage of photoreceptor membrane lipids and proteins induced by photosensitized generation of singlet oxygen. Curr Eye Res. 1982;2:683-689.
57. 3H]glycerol metabolism of phosphatidic acid from photoreceptor membranes. Biochim Biophys Acta. 1982;712:702-706.
58. Bazan NG. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res. 1989;312:95-112.
59. Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B. Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism: a physiologically-significant process? Biochem Pharmacol. 1991;42:735-743.
60. Yue TL, Cheng HY, Lysko PG, et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther. 1992;263:92-98.
61. Huang YC, Wu BN, Yeh JL, et al. A new aspect of view in synthesizing new type beta-adrenoceptor blockers with ancillary antioxidant activities. Bioorg Med Chem. 2001;9:1739-1746.
62. Tan AY, LeVatte TL, Archibald ML, Tremblay F, Kelly MEM, Chauhan BC. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing. J Glaucoma. 2002;11:134-142.
63. Wood JP, Schmidt KG, Melena J, Chidlow G, Allmeier H, Osborne NN. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res. 2003;76:505-516.
64. Kessler C, Bleckmann H, Kleintges G. Influence of the concentration of metipranolol eye drops on the drug concentration in human aqueous humour. Graefes Arch Clin Exp Ophthalmol. 1991;229:487-491.